Erratum to: J Nanobiotechnol DOI 10.1186/s12951-015-0068-6
Panel A, B, and C from Figure 7 (Fig. 1 here) of this work [1] was generated using HepG2, SMMC7721, and NIH 3T3 cells, respectively. After publication of this work, we noted that they were inadvertently labelled as NIH 3T3, HepG2 and SMMC7721 cells. The figure caption of Figure 7 has now been corrected in this erratum.
Flow cytometry study. ASGPR-positive cells HepG2 (A) and SMMC7721 (B), and ASGPR-negative cells NIH 3T3 (C) incubated with blank medium (control), Lac-MSNs, MSNs, and excess free lactose with Lac-MSNs for 4 h at 37°C. Data represent mean ± SD (n = 3).
Reference
Quan GL, Pan X, Wang ZH, Wu QL, Li G, Dian LH et al (2015) Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery. J Nanobiotech 13:7
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found under doi:10.1186/s12951-015-0068-6.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Quan, G., Pan, X., Wang, Z. et al. Erratum to: Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery. J Nanobiotechnol 13, 89 (2015). https://doi.org/10.1186/s12951-015-0104-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12951-015-0104-6